Pathway Browser

Visualize and interact with Reactome biological pathways

Analysis Tools

Merges pathway identifier mapping,
over-representation, and expression analysis

ReactomeFIViz

Designed to find pathways and network patterns related to cancer and other types of diseases

Documentation

Information to browse the database and use its principal tools for data analysis

Reactome Research Spotlight

Reactome pathway enrichment analysis helps to pinpoint expansion of regulatory T cells as a new biomarker of CAR T cell therapy resistance and toxicity in patients with B cell lymphoma. The study was published by Good et al. in Nature Medicine on September 12, 2022.

ARCHIVE

Why Reactome

Reactome is a free, open-source, curated and peer-reviewed pathway database. Our goal is to provide intuitive bioinformatics tools for the visualization, interpretation and analysis of pathway knowledge to support basic research, genome analysis, modeling, systems biology and education. 

European Bioinformatics Institute (EMBL-EBI)
NYU Langone Health
Oregon Health & Science University
Ontario Institute for Cancer Research

The development of Reactome is supported by grants from the US National Institutes of Health (U24 HG012198) and the European Molecular Biology Laboratory.

Tweets

Version 82 released on September 20, 2022

2,601

Human Pathways

14,398

Reactions

11,393

Proteins

1,998

Small Molecules

1,035

Drugs

35,965

Literature References

Cite Us!